NEW ANTICOAGULANT STRATEGIES - CURRENT STATUS AND FUTURE POTENTIAL

被引：44
作者：
WEITZ, J [1 ]
机构：
[1] MCMASTER UNIV,HAMILTON,ON,CANADA
来源：
DRUGS | 1994年 / 48卷 / 04期
关键词：
D O I：
10.2165/00003495-199448040-00001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：485 / 497
页数：13
相关论文
共 42 条
[1]  
AGNELLI G, 1992, BLOOD, V80, P960
[2]   BINDING OF THROMBIN TO SUBENDOTHELIAL EXTRACELLULAR-MATRIX - PROTECTION AND EXPRESSION OF FUNCTIONAL-PROPERTIES [J].
BARSHAVIT, R ;
ELDOR, A ;
VLODAVSKY, I .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1096-1104
[3]  
CANNON CP, 1993, J AM COLL CARDIOL, V21, P136
[4]   A NEW MURINE MONOCLONAL-ANTIBODY REPORTS AN ACTIVATION-DEPENDENT CHANGE IN THE CONFORMATION AND OR MICROENVIRONMENT OF THE PLATELET GLYCOPROTEIN IIB/IIIA COMPLEX [J].
COLLER, BS .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (01) :101-108
[5]   PLATELETS AND THROMBOLYTIC THERAPY [J].
COLLER, BS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :33-42
[6]  
DEBONO DP, 1992, BRIT HEART J, V67, P122
[7]   FACTORS RESPONSIBLE FOR THE DIFFERENTIAL PROCOAGULANT EFFECTS OF DIVERSE PLASMINOGEN ACTIVATORS IN PLASMA [J].
EISENBERG, PR ;
MILETICH, JP ;
SOBEL, BE .
FIBRINOLYSIS, 1991, 5 (04) :217-224
[8]   SAFETY AND ANTIPLATELET EFFECT OF MURINE MONOCLONAL-ANTIBODY 7E3 FAB DIRECTED AGAINST PLATELET GLYCOPROTEIN-IIB/IIIA IN PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOPLASTY [J].
ELLIS, SG ;
TCHENG, JE ;
NAVETTA, FI ;
MULLER, DWM ;
WEISMAN, HF ;
SMITH, C ;
ANDERSON, KM ;
CALIFF, RM ;
TOPOL, EJ .
CORONARY ARTERY DISEASE, 1993, 4 (02) :167-175
[9]  
ERIKSSON BI, 1992, CIRCULATION, V86, P410
[10]  
FRANCIS CW, 1983, J LAB CLIN MED, V102, P220
12345